Search results for "Cardiovascular Disease"
Melatonin not associated with increased diabetes, cardiovascular disease risk
Researchers reviewed data from three longitudinal studies of health care professionals to parse out potential effects of self-reported melatonin use on overall health.
https://immattersacp.org/weekly/archives/2024/05/14/2.htm
14 May 2024
Considerations about cannabis
As more states legalize recreational and medical cannabis, hospital physicians are finding themselves caring for regular users more frequently.
https://immattersacp.org/archives/2024/05/considerations-about-cannabis.htm
1 May 2024
SGLT-2 inhibitors more effective than sulfonylureas, DPP-4 inhibitors as second-line therapy
Patients with type 2 diabetes who added a sodium-glucose cotransporter-2 (SGLT-2) inhibitor to metformin had greater reductions in HbA1c level and body mass at one year than those who added a sulfonylurea or dipeptidyl peptidase-4 (DPP-4) inhibitor, a U.K. study found.
https://immattersacp.org/weekly/archives/2024/05/14/4.htm
14 May 2024
Low testosterone levels in men associated with mortality risk
Data from this new systematic review support the hypothesis that hypogonadism is associated with higher cardiovascular and/or all-cause mortality, an accompanying editorial stated.
https://immattersacp.org/weekly/archives/2024/05/14/1.htm
14 May 2024
New 'weighs' to treat obesity
Even as the data on weight loss drugs mount, physicians need to help patients navigate potentially prohibitive costs and a continuing need for lifestyle change.
https://immattersacp.org/archives/2024/03/new-weighs-to-treat-obesity.htm
1 Mar 2024
Anxiety, depression treatment linked with improved outcomes in cardiovascular disease
Patients who had been hospitalized and had both cardiovascular disease and a mental health condition were 75% less likely to be readmitted if they received psychotherapy and medication for their anxiety or depression.
https://immattersacp.org/weekly/archives/2024/03/26/4.htm
26 Mar 2024
First NASH treatment, over-the-counter CGM approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/05/first-nash-treatment-over-the-counter-cgm-approved.htm
1 May 2024
EHR alert had small effect on lipid therapy in highest-risk patients
A trial alert nudged clinicians seeing patients with very high-risk atherosclerotic cardiovascular disease to intensify therapy by prescribing a high-intensity statin, adding ezetimibe, or prescribing a proprotein subtilisin/kexin type 9 inhibitor.
https://immattersacp.org/weekly/archives/2024/04/30/4.htm
30 Apr 2024
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/04/latest-updates-on-acps-priorities-initiatives.htm
1 Apr 2024
Statins underused in patients with cardiovascular disease, study finds
Women, older adults, and those with peripheral artery disease and cerebrovascular disease are particularly likely not to receive statins, according to an industry-funded analysis of lipid-lowering therapy use.
https://immattersacp.org/weekly/archives/2023/08/08/2.htm
8 Aug 2023